MCFT
MasterCraft Boat Holdings, Inc.
MCFT trails on the overall score without a compensating advantage in the available component scores.
RIVN
Rivian Automotive, Inc.
RIVN has the edge over MCFT overall, supported by stronger modeled upside and stronger valuation.
MCFT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Healthy | |
| Strong |
MCFT's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MCFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.7x | $1.21 | -94% |
| Fair | 9.3x | $1.67 | -92% |
| Expensive | 24x | $4.36 | -80% |
| Current | 120x | $21.59 | — |
Historical ranges are pointers, not guarantees.
MCFT's PE is in its expensive range at 120x.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
MCFT Forward outlook
There aren't enough analyst estimates for MCFT to show an outlook.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RIVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
MCFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.18 | -81% |
| Q2 2026 | -$0.10 | -123% |
| Q1 2026 | $0.68 | +$1.05 |
| Q4 2025 | $0.96 | +$1.34 |
| Q3 2025 | $0.97 | +$1.18 |
| Q2 2025 | $0.44 | -4.3% |
| Q1 2025 | -$0.37 | -117% |
| Q4 2024 | -$0.38 | -112% |
MCFT has the edge over RIVN on earnings quality, reporting a profit while its opponent remains loss making.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
MCFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $154.1M | +123% |
| Q2 2026 | $129.9M | +63% |
| Q1 2026 | $78.2M | +3% |
| Q4 2025 | $71.8M | +13% |
| Q3 2025 | $69M | +5.6% |
| Q2 2025 | $79.5M | +18% |
| Q1 2025 | $76M | -21% |
| Q4 2024 | $63.4M | -36% |
MCFT's revenue is recovering but still below its 2022 peak: $154M last quarter, up 123% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.8% | +2.3 points |
| Q2 2026 | -4.9% | -12 points |
| Q1 2026 | -1.7% | -7.1 points |
| Q4 2025 | 3.8% | +3.5 points |
| Q3 2025 | 5.5% | +3.9 points |
| Q2 2025 | 7.5% | +25 points |
| Q1 2025 | 5.4% | +1.2 points |
| Q4 2024 | 0.3% | -6.8 points |
MCFT has the edge over RIVN on profitability, with a higher operating margin.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN has the edge over MCFT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
MCFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.9M | +$12.8M |
| Q2 2026 | $14.6M | -18% |
| Q1 2026 | $3.8M | -13% |
| Q4 2025 | $14M | +245% |
| Q3 2025 | -$9.9M | -5083% |
| Q2 2025 | $17.9M | +$31.4M |
| Q1 2025 | $4.3M | +$5.2M |
| Q4 2024 | $4M | -83% |
MCFT has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
MCFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.8x | Net Cash |
| Q2 2026 | -3.5x | Net Cash |
| Q1 2026 | -3.7x | Net Cash |
| Q4 2025 | -2.2x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | -8.8x | Net Cash |
| Q4 2024 | -10.1x | Net Cash |
MCFT has more cash than debt.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MCFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.0 | Neutral |
| Stochastic | 32.4 | Neutral |
MCFT's weekly RSI is 49 (neutral) and its Stochastic is 32 (neutral).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
MCFT PE vs Consumer Cyclical Sector
| Metric | MCFT | Sector median | Relative |
|---|---|---|---|
| PE | 120x | 18x | 565% above |
| PE % | 100 | 47 | 53 pts above |
MCFT is trading at 120x earnings, a 565% premium to the Consumer Cyclical sector's median of 18x.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
MCFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.4 | 6.1% above |
| 20 week MA | $22.3 | 3.2% below |
| 50 week MA | $22.1 | 2.4% below |
| 100 week MA | $20.5 | 5.2% above |
| 200 week MA | $22.0 | 1.8% below |
MCFT has the edge over RIVN on trend strength, trading above more of its moving averages.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
MCFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.4 | $26.7 | +73% |
| 2021 | $26.7 | $26.3 | -1.6% |
| 2022 | $26.3 | $26.2 | -0.3% |
| 2023 | $26.2 | $22.6 | -14% |
| 2024 | $22.6 | $18.7 | -17% |
| 2025 | $18.7 | $19.5 | +4.1% |
| 2026 YTD | $19.5 | $21.6 | +11% |
MCFT has the edge over RIVN on returns for 2026, with the stronger performance.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.